Diagnostic performance and application of two commercial cell viability assays in foot-and-mouth disease research

Journal of Virological Methods

Volumn 173, Issue 1, 2011, Pages 108-114

  Willems, Tom ^a   Lefebvre, David J ^a   Neyts, Johan ^b,c   De Clercq, Kris ^a  

^a VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^c Okapi Sciences NV   (Belgium)

Author keywords

Antiviral compound screening; Cell viability assay; Cytopathic effect; Foot and mouth disease; Virus neutralization test

Indexed keywords

2' METHYLCYTIDINE; ANTIVIRUS AGENT; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; CATTLE DISEASE; CELL ASSAY; CELL CULTURE; CELL VIABILITY ASSAY; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG SCREENING; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VIRUS NEUTRALIZATION;

BOS; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 79952187940     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.01.015     Document Type: Article

References (36)

1. Amadori M., Archetti I.L., Tollis M., Buonavoglia C., Panina G.F. Potency assessment of foot-and-mouth disease vaccines in cattle by means of antibody assays. Biologicals 1991, 19:191-196.
2. Andersson P., Alm S., Edman K., Lindberg A.M. A novel and rapid method to quantify cytolytic replication of picornaviruses in cell culture. J. Virol. Methods 2005, 130:117-123.
3. Barnett P.V., Statham R.J., Vosloo W., Haydon D.T. Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach. Vaccine 2003, 21:3240-3248.
4. Brehm K.E., Kumar N., Thulke H.H., Haas B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease. Vaccine 2008, 26:1681-1687.
5. Cohen J. A coefficient of agreement for nominal scales. Educ. Psychol. Meas. 1960, 20:37-46.
6. Doel T.R. Optimisation of the immune response to foot-and-mouth disease vaccines. Vaccine 1999, 17:1767-1771.
7. Erb R.E., Ehlers M.H. Resazurin reducing time as an indicator of bovine semen fertilizing capacity. J. Dairy Sci. 1950, 33:853-864.
8. Golde W.T., Pacheco J.M., Duque H., Doel T., Penfold B., Ferman G.S., Gregg D.R., Rodriguez L.L. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 2005, 23:5775-5782.
9. Gonzalez R.J., Tarloff J.B. Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity. Toxicol. In Vitro 2001, 15:257-259.
10. Goris N., De Palma A., Toussaint J.F., Musch I., Neyts J., De Clercq K. 2′-C-methylcytidine as a potent and selective inhibitor of the replication of foot-and-mouth disease virus. Antiviral Res. 2007, 73:161-168.
11. Goris N., Vandenbussche F., De Clercq K. Potential of antiviral therapy and prophylaxis for controlling RNA viral infections of livestock. Antiviral Res. 2008, 78:170-178.
12. Goris N., Willems T., Diev V.I., Merkelbach-Peters P., Vanbinst T., Van der Stede Y., Kraft H.P., Zakharov V.M., Borisov V.V., Nauwynck H.J., Haas B., De Clercq K. Indirect foot-and-mouth disease vaccine potency testing based on a serological alternative. Vaccine 2008, 26:3870-3879.
13. Heldt C.L., Hernandez R., Mudiganti U., Gurgel P.V., Brown D.T., Carbonell R.G. A colorimetric assay for viral agents that produce cytopathic effects. J. Virol. Methods 2006, 135:56-65.
14. Larson E.M., Doughman D.J., Gregerson D.S., Obritsch W.F. A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Invest. Ophthalmol. Vis. Sci. 1997, 38:1929-1933.
15. Li Q., Maddox C., Rasmussen L., Hobrath J.V., White L.E. Assay development and high-throughput antiviral drug screening against Bluetongue virus. Antiviral Res. 2009, 83:267-273.
16. Loeffler F., Frosch P. Summarischer Bericht ueber die Ergebnisse der Untersuchungen der Kommission zur Erforschung der Maul- und Klauenseuche bei dem Institut fuer Infektionskrankheiten in Berlin. Zent Bakt Parasikde Abt. I 1897, 22:257-259.
17. Loeffler F., Frosch P. Berichte der Kommission zur Erforschung der Maul- und Klauenseuche bei dem Institut fuer Infektionskrankheiten in Berlin. Zent Bakt Parasikde Abt. I 1898, 23:371-391.
18. Maradei E., La Torre J., Robiolo B., Esteves J., Seki C., Pedemonte A., Iglesias M., D'Aloia R., Mattion N. Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in Argentina. Vaccine 2008, 26:6577-6586.
19. Mattion N., Goris N., Willems T., Robiolo B., Maradei E., Beascoechea C.P., Perez A., Smitsaart E., Fondevila N., Palma E., De Clercq K., La Torre J. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology. Vaccine 2009, 27:741-747.
20. McCullough K.C., Bruckner L., Schaffner R., Fraefel W., Muller H.K., Kihm U. Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet. Microbiol. 1992, 30:99-112.
21. McMillian M.K., Li L., Parker J.B., Patel L., Zhong Z., Gunnett J.W., Powers W.J., Johnson M.D. An improved resazurin-based cytotoxicity assay for hepatic cells. Cell Biol. Toxicol. 2002, 18:157-173.
22. Newcombe R.G. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat. Med. 1998, 17:857-872.
23. O'Brien J., Wilson I., Orton T., Pognan F. Investigation of the Alamar blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267:5421-5426.
24. OIE, World Organisation for Animal Health Foot and mouth disease. Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, Chapter 2.1.5 2009, http://www.oie.int/eng/normes/mmanual/2008/pdf/2.01.05_FMD.pdf (accessed 18.06.10.).
25. Parandoosh Z., Bogowitz C.A., Nova M.P. A fluorometric assay for the measurement of endothelial cell density in vitro. In Vitro Cell. Dev. Biol. Anim. 1998, 34:772-776.
26. Paton D.J., Valarcher J.F., Bergmann I., Matlho O.G., Zakharov V.M., Palma E.L., Thomson G.R. Selection of foot and mouth disease vaccine strains - a review. Rev. Sci. Tech. 2005, 24:981-993.
27. Periolo O.H., Seki C., Grigera P.R., Robiolo B., Fernández G., Maradei E., D'Aloia R., La Torre J.L. Large-scale use of liquid-phase blocking sandwich ELISA for the evaluation of protective immunity against aphthovirus in cattle vaccinated with oil-adjuvanted vaccines in Argentina. Vaccine 1993, 11:754-760.
28. Reed L.J., Münch H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
29. Robiolo B., Grigera P.R., Periolo O.H., Seki C., Bianchi T., Maradei E., La Torre J.L. Assessment of foot and mouth disease vaccine potency by liquid-phase blocking ELISA: a proposal for an alternative to the challenge procedure in Argentina. Vaccine 1995, 13:1346-1352.
30. Robiolo B., La Torre J., Duffy S., Leon E., Seki C., Torres A., Mattion N. Quantitative single serum-dilution liquid phase competitive blocking ELISA for the assessment of herd immunity and expected protection against foot-and-mouth disease virus in vaccinated cattle. J. Virol. Methods 2010, 166:21-27.
31. Rweyemamu M., Roeder P., Mackay D., Sumption K., Brownlie J., Leforban Y., Valarcher J.F., Knowles N.J., Saraiva V. Epidemiological patterns of foot-and-mouth disease worldwide. Transbound. Emerg. Dis. 2008, 55:57-72.
32. Severson W.E., Shindo N., Sosa M., Fletcher T., White E.L., Ananthan S., Jonsson C.B. Development and validation of a high-throughput screen for inhibitors of SARS CoV and its application in screening of a 100,000-compound library. J. Biomol. Screen. 2007, 12:33-40.
33. Squatrito R.C., Connor J.P., Buller R.E. Comparison of a novel redox dye cell growth assay to the ATP bioluminescence assay. Gynecol. Oncol. 1995, 58:101-105.
34. Van Maanen C., Terpstra C. Comparison of a liquid-phase blocking sandwich ELISA and a serum neutralization test to evaluate immunity in potency tests of foot-and-mouth disease vaccines. J. Immunol. Methods 1989, 124:111-119.
35. Wilson E.B. Probable inference, the law of succession, and statistical inference. J. Am. Stat. Assoc. 1927, 22:209-212.
36. Zhang J.H., Chung T.D., Oldenburg K.R. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 1999, 4:67-73.